D.E. Shaw & Co
STAA icon

D.E. Shaw & Co’s STAAR Surgical STAA Stock Holding History

D.E. Shaw & Co’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$521K Buy
27,846
+10,209
+58% +$195K ﹤0.01% 3837
2025
Q4 		$407K Sell
17,637
-295
-2% -$7.6K ﹤0.01% 4016
2025
Q3 		$482K Sell
17,932
-106,355
-86% -$2.54M ﹤0.01% 3876
2025
Q2 		$2.09M Buy
124,287
+83,509
+205% +$1.47M ﹤0.01% 2713
2025
Q1 		$719K Sell
40,778
-9,471
-19% -$190K ﹤0.01% 3293
2024
Q4 		$1.22M Buy
+50,249
New +$1.43M ﹤0.01% 3092
2024
Q3 		– Sell
-122,717
Closed -$5.84M – 4868
2024
Q2 		$5.84M Buy
122,717
+98,786
+413% +$4.33M 0.01% 1734
2024
Q1 		$916K Sell
23,931
-57,175
-70% -$1.86M ﹤0.01% 3145
2023
Q4 		$2.53M Buy
+81,106
New +$2.91M ﹤0.01% 2487
2023
Q3 		– Sell
-20,406
Closed -$1.07M – 4479
2023
Q2 		$1.07M Sell
20,406
-9,203
-31% -$560K ﹤0.01% 3041
2023
Q1 		$1.89M Sell
29,609
-21,887
-43% -$1.43M ﹤0.01% 2730
2022
Q4 		$2.5M Buy
51,496
+2,598
+5% +$163K ﹤0.01% 2745
2022
Q3 		$3.45M Sell
48,898
-2,011
-4% -$172K ﹤0.01% 2474
2022
Q2 		$3.61M Buy
50,909
+11,225
+28% +$723K ﹤0.01% 2531
2022
Q1 		$3.17M Buy
39,684
+32,646
+464% +$2.43M ﹤0.01% 2828
2021
Q4 		$643K Buy
+7,038
New +$755K ﹤0.01% 4255
2020
Q3 		– Sell
-33,045
Closed -$2.03M – 4147
2020
Q2 		$2.03M Buy
33,045
+26,513
+406% +$1.08M ﹤0.01% 2400
2020
Q1 		$211K Buy
+6,532
New +$220K ﹤0.01% 3624
2019
Q2 		– Sell
-15,662
Closed -$535K – 3854
2019
Q1 		$535K Sell
15,662
-30,931
-66% -$1.09M ﹤0.01% 2973
2018
Q4 		$1.49M Sell
46,593
-160,167
-77% -$6.24M ﹤0.01% 2387
2018
Q3 		$9.92M Sell
206,760
-204,640
-50% -$8.38M 0.01% 1125
2018
Q2 		$12.8M Buy
411,400
+327,625
+391% +$7.67M 0.02% 953
2018
Q1 		$1.24M Buy
83,775
+44,432
+113% +$694K ﹤0.01% 2355
2017
Q4 		$610K Buy
39,343
+15,933
+68% +$237K ﹤0.01% 2864
2017
Q3 		$291K Sell
23,410
-3,383
-13% -$37.7K ﹤0.01% 3154
2017
Q2 		$289K Sell
26,793
-16,781
-39% -$164K ﹤0.01% 3052
2017
Q1 		$427K Sell
43,574
-34
-0.1% -$339 ﹤0.01% 2807
2016
Q4 		$473K Buy
43,608
+14,772
+51% +$150K ﹤0.01% 2883
2016
Q3 		$271K Buy
28,836
+16,211
+128% +$130K ﹤0.01% 3089
2016
Q2 		$70K Sell
12,625
-46,747
-79% -$302K ﹤0.01% 3277
2016
Q1 		$439K Sell
59,372
-2,236
-4% -$15.1K ﹤0.01% 2850
2015
Q4 		$440K Buy
61,608
+11,594
+23% +$94K ﹤0.01% 3157
2015
Q3 		$388K Buy
+50,014
New +$412K ﹤0.01% 3223
2014
Q2 		– Sell
-14,600
Closed -$274K – 4512
2014
Q1 		$274K Buy
+14,600
New +$235K ﹤0.01% 3950
2013
Q3 		– Sell
-90,953
Closed -$923K – 4456
2013
Q2 		$923K Buy
+90,953
New +$736K ﹤0.01% 2784

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's STAA Position: Q1 2026 in Review

D.E. Shaw & Co increased its STAAR Surgical (STAA) stake by 58% in Q1 2026, buying an estimated $195K and bringing the position to 27,846 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

D.E. Shaw & Co first reported a position in STAA in Q2 2013 and has held it in 35 quarters since. The position peaked at $12.8M in Q2 2018. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • D.E. Shaw & Co held 27,846 shares of STAAR Surgical worth $521K as of Q1 2026.
  • D.E. Shaw & Co bought 10,209 STAAR Surgical shares in Q1 2026, an estimated $195K.
  • STAAR Surgical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3837 holding.
  • D.E. Shaw & Co first reported a position in STAAR Surgical in Q2 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's STAAR Surgical position peaked at $12.8M in Q2 2018.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.